8-K: Nanophase Technologies Reports Record Third Quarter Revenue and Profit, Solsence Growth Soars

Nanophase Technologies announced record third-quarter revenue of $16.9 million and a profit of $3 million, driven by a 171% year-over-year increase in Solsence revenue.

Summary

• Nanophase Technologies Corporation reported record financial results for the third quarter ended September 30, 2024.
• Third-quarter revenue reached a record $16.9 million, a 112% increase compared to $8 million in the same period of 2023.
• Solsence revenue was $13.6 million, a 171% increase compared to $5 million in the same period of 2023.
• Gross profit for the third quarter was a record $6.1 million, a 299% increase compared to $1.5 million in the same period of 2023.
• Net income for the third quarter was a record $3 million, compared to a net loss of $1.4 million in the same period of 2023.
• Nine-month revenue for 2024 reached a record $39.8 million, a 36% increase over the same period in 2023 and exceeding full-year 2023 revenue by $2.5 million.
• Net income for the nine months ended September 30 was $4.8 million, a $7.1 million swing from the $2.3 million loss in the same period in 2023.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to record financial results, significant growth in the Solsence business, and optimistic management commentary. The company's performance is significantly better than the previous year, and the future outlook is positive.

Positives

• The company achieved record revenue, gross profit, operating income, and net income in the third quarter.
• Solsence business is experiencing dynamic growth, significantly contributing to the overall revenue increase.
• The company's nine-month revenue for 2024 has already exceeded its full-year 2023 revenue by $2.5 million.
• The company has expanded its manufacturing capabilities and implemented additional automation.
• The company added three new ISO 6 clean rooms, increasing capacity for new opportunities.
• The company's strategy is showing positive results, and management is optimistic about the future.

Risks

• The company is dependent on a limited number of key customers, and a cancellation of a purchase order or supply agreement could negatively impact results.
• There is uncertain demand for and acceptance of the company's engineered materials, ingredients, and fully formulated products.
• The company's manufacturing capacity and product mix flexibility could be challenged by customer demand.
• The company has limited marketing experience.
• Changes in development and distribution relationships could impact the company.
• The company faces competition from other products and technologies.
• The company is dependent on patents and protection of proprietary information.
• The company could be involved in litigation.
• New government regulations could be difficult or costly to comply with.
• The company needs to maintain an appropriate electronic trading venue.

Future Outlook

The company is optimistic about its future and looks forward to sharing more during the conference call. The company's strategy is bearing fruit.

Management Comments

• Jess Jankowski, President and Chief Executive Officer, stated that 2024 continues to be the breakout year that they had expected.
• Kevin Cureton, Chief Operating Officer, noted that the nine-month revenue for 2024 has already exceeded the full-year 2023 revenue by $2.5 million.
• Jess Jankowski concluded that the company looks forward to sharing more during their call tomorrow.

Industry Context

The results indicate strong growth in the mineral-based healthcare solutions market, particularly in the beauty and life science categories. The success of Solsence highlights the increasing demand for innovative and clean beauty products.

Comparison to Industry Standards

• Nanophase's 112% revenue growth in Q3 significantly outpaces the average growth rate in the specialty materials sector, which typically sees single-digit growth.
• The 171% growth in Solsence revenue is exceptional compared to the average growth of 10-20% in the clean beauty market, indicating a strong competitive advantage.
• The swing from a $1.4 million loss to a $3 million profit in Q3 is a significant improvement, suggesting effective cost management and operational efficiency gains.
• Comparable companies in the advanced materials space, such as Cabot Corporation and Materion, typically report more modest growth rates, making Nanophase's performance stand out.
• The expansion of clean room facilities and automation implementation positions Nanophase well for future growth, aligning with industry trends towards increased production capacity and efficiency.

Stakeholder Impact

• Shareholders will benefit from the improved financial performance and positive outlook.
• Employees will benefit from the company's growth and expansion.
• Customers will benefit from the company's innovative products and solutions.
• Suppliers will benefit from the company's increased production and demand.
• Creditors will benefit from the company's improved financial stability.

Next Steps

• The company will host a third-quarter conference call on October 31, 2024, to discuss financial results and provide a business and financial update.
• The company will continue to focus on expanding its production capacity and improving labor efficiency.
• The company will continue to leverage its platform of integrated, patented and proprietary technologies to create products with unique performance.

Key Dates

Keywords

Nanophase Technologies, Solsence, mineral-based, healthcare solutions, beauty, life science, revenue, profit, gross profit, net income, automation, clean rooms, manufacturing